Community News
-
No change to factor IX product mix in Quebec
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022...
-
2022 James Kreppner Memorial Scholarship and Bursary Program recipients
In an effort to bring young volunteers into the CHS, and in recognition that a sound education is of utmost importance particularly for those who...
-
The FactorFirst card has been revised
The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...
-
Important CHS survey on gene therapy
Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best...
-
Blood donation: dispelling a myth
Eligibility for blood donation in Canada is constantly evolving. For many years, the sexual partners of people with bleeding disorders were deferred from blood donation....